In the BioHarmony Drug Report Database

"Preview" Icon

Dimethyl fumarate

Tecfidera, Skilarence (dimethyl fumarate) is a small molecule pharmaceutical. Dimethyl fumarate was first approved as Tecfidera on 2013-03-27. It has been approved in Europe to treat multiple sclerosis and psoriasis. Tecfidera’s patents are valid until 2035-11-16 (FDA).

 

Trade Name

 

Skilarence, Tecfidera
 

Common Name

 

dimethyl fumarate
 

ChEMBL ID

 

CHEMBL2107333
 

Indication

 

multiple sclerosis, psoriasis
 

Drug Class

 

Image (chem structure or protein)

Dimethyl fumarate structure rendering